[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100481486":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":36,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":42,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":21,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"University Hospital, Gentofte, Copenhagen","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP)",null,"The overall inclusion criteria of patients in the HP cohort are:\n\n* Diagnosis of HP at an MDT conference according to the current international guidelines\n* Age of 18 years or older\n* The patients must be capable of giving informed consent",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Nils Hoyer, PhD","CONTACT","+45-3867 4200","nils.hoyer@regionh.dk",[19],{"facility":20,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Department of respiratory medicine","RECRUITING","Hellerup","Copenhagen","2900","Denmark","DK",{"type":28,"coordinates":29},"Point",[30,31],12.57093,55.73204,{"lat":31,"lon":30},[34],{"name":14,"role":15,"phone":35,"phoneExt":10,"email":17},"+45 50589495",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Nils Hoyer","Principal Investigator","100481486","database-and-biobank-of-patients-with-hypersensitivity-pneumonitis-100481486",false,"NCT05549635","Database and Biobank of Patients With Hypersensitivity Pneumonitis","Pulmonary Fibrosis Biobank - Hypersensitivity Pneumonitis","PFBIO-HP","Inclusion Criteria:\n\n* Diagnosis of HP at an MDT conference according to the current international guidelines\n* Age of 18 years or older\n* The patients must be capable of giving informed consent\n\nExclusion Criteria:\n\n\\- Unable to sign informed consent","ALL","18 Years",{"count":51,"type":52},50,"ESTIMATED","OBSERVATIONAL","Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data.\n\nThe database and biobank will be available for studies of HP, and can be directly compared to the main PFBIO cohort, which has recruited patients with Idiopathic pulmonary Fibrosis (IPF) since 2016.\n\nBiomarkers will be assessed as diagnostic and prognostic. Further subtyping of HP, based on blood markers (including precipitins) will also be possible with the PFBIO-HP project.",[56],"Hypersensitivity Pneumonitis",[58,59,60,61,62],"biomarker","prognosis","diagnosis","phenotyping","genotyping","2023-12-21",{"date":65,"type":66},"2023-12-22","ACTUAL",{"date":68,"type":66},"2022-09-18",{"date":70,"type":52},"2028-12-31",{"name":38,"class":6},1]